TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
July 14, 2023Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign "Today's announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline, offers...
Read moreAccess to medicines
February 6, 2019Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...
Read more